MircroPort Medbot-B

Forecast & Rating10 analysts currently cover MircroPort Medbot-B, with about 90.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$36.16, about 52.2% upside from the current price of HK$23.76. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 30.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study MircroPort Medbot-B closely still see room for the stock to rise. Data as of Aug 7, 2026; for reference only and not investment advice.